-
公开(公告)号:US20180223249A1
公开(公告)日:2018-08-09
申请号:US15749037
申请日:2016-08-03
Applicant: Regeneron Pharmaceuticals, Inc.
Inventor: Amy S. JOHNSON , Meghan E. CASEY , Shadia OSHODI , Shawn LAWRENCE
IPC: C12N5/00
CPC classification number: C12N5/0018 , C12N15/79 , C12N2500/33 , C12N2500/74 , C12N2500/80
Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
-
公开(公告)号:US20210388408A1
公开(公告)日:2021-12-16
申请号:US17409193
申请日:2021-08-23
Applicant: Regeneron Pharmaceuticals, Inc.
Inventor: John CHEN , Shawn LAWRENCE , Amy JOHNSON , Theodore LONEY , Ravindra PANGULE , Ta-Chun HANG , Scott CARVER , Bernhard SCHILLING
IPC: C12P21/00 , C07K14/47 , C07K14/715 , C07K14/71
Abstract: The instant application provides a method for screening batches of soy hydrolysate for a desired amount of a component thereof, such as ornithine or putrescine, and selecting only those batches of soy hydrolysate that have a desired amount of such component. The present disclosure also sets forth methods for culturing cells in media supplemented with selected batches of soy to produce more consistent, high quality lots of a protein of interest. Further, the present disclosure provides a plurality of protein preparations that have each been produced by culturing cells in media supplemented with separate batches of soy hydrolysate containing a desired amount of ornithine or putrescine, whereby each batch of protein produced exhibits improved quality of the protein of interest or amount of quality protein produced.
-
公开(公告)号:US20230063116A1
公开(公告)日:2023-03-02
申请号:US17782508
申请日:2020-12-04
Applicant: REGENERON PHARMACEUTICALS, INC.
Inventor: Joel MARTIN , Samuel DAVIS , Shawn LAWRENCE , Amy JOHNSON , Meghan CASEY , Jaimie MASTROGIACOMO , Shunhai WANG , Ning LI , Andrew TUSTIAN , Ankit VARTAK , Matthew FRANKLIN
Abstract: The present invention provides VEGF mini-trap molecules and method of treating or preventing angiogenic disorders such as angiogenic eye disorders and cancer.
-
公开(公告)号:US20210087535A1
公开(公告)日:2021-03-25
申请号:US16984531
申请日:2020-08-04
Applicant: Regeneron Pharmaceuticals, Inc.
Inventor: Shawn LAWRENCE , Ann KIM , Amy S. JOHNSON
Abstract: An improved method for large scale production of proteins and/or polypeptides in cell culture is provided. In accordance with the present invention, the method provides for culturing cells that have metabolically shifted. The use of such a method or system allows high levels of protein or polypeptide production and reduces accumulation of unwanted metabolic waste such as lactate. Proteins and polypeptides expressed in accordance with the present invention may be advantageously used in the preparation of pharmaceutical, immunogenic, or other commercial biologic compositions, such as antibodies.
-
公开(公告)号:US20220315644A1
公开(公告)日:2022-10-06
申请号:US17843121
申请日:2022-06-17
Applicant: REGENERON PHARMACEUTICALS, INC.
Inventor: Shawn LAWRENCE , Michelle LAFOND , Ann KIM , Amy S. JOHNSON , Brandon VERES , Mark CZETERKO , Kristen WHALEN
Abstract: Improved methods for large scale production of proteins and/or polypeptides in cell culture is provided. In accordance with the present invention, the method provides for culturing cells that have metabolically shifted. The use of such a method or system allows high levels of protein or polypeptide production and reduces accumulation of unwanted metabolic waste such as lactate. Proteins and polypeptides expressed in accordance with the present invention may be advantageously used in the preparation of pharmaceutical, immunogenic, or other commercial biologic compositions, such as antibodies.
-
公开(公告)号:US20210388407A1
公开(公告)日:2021-12-16
申请号:US17409158
申请日:2021-08-23
Applicant: Regeneron Pharmaceuticals, Inc.
Inventor: John CHEN , Shawn LAWRENCE , Amy JOHNSON , Theodore LONEY , Ravindra PANGULE , Ta-Chun HANG , Scott CARVER , Bernhard SCHILLING
IPC: C12P21/00 , C07K14/47 , C07K14/715 , C07K14/71
Abstract: The instant application provides a method for screening batches of soy hydrolysate for a desired amount of a component thereof, such as ornithine or putrescine, and selecting only those batches of soy hydrolysate that have a desired amount of such component. The present disclosure also sets forth methods for culturing cells in media supplemented with selected batches of soy to produce more consistent, high quality lots of a protein of interest. Further, the present disclosure provides a plurality of protein preparations that have each been produced by culturing cells in media supplemented with separate batches of soy hydrolysate containing a desired amount of ornithine or putrescine, whereby each batch of protein produced exhibits improved quality of the protein of interest or amount of quality protein produced.
-
公开(公告)号:US20200157492A1
公开(公告)日:2020-05-21
申请号:US16742670
申请日:2020-01-14
Applicant: Regeneron Pharmaceuticals, Inc.
Inventor: Amy S. JOHNSON , Meghan E. CASEY , Shadia OSHODI , Shawn LAWRENCE
IPC: C12N5/00
Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
-
公开(公告)号:US20160244725A1
公开(公告)日:2016-08-25
申请号:US15028521
申请日:2014-10-10
Applicant: REGENERON PHARMACEUTICALS, INC.
Inventor: Shawn LAWRENCE , Ann KIM , Amy S. JOHNSON
IPC: C12N5/071
CPC classification number: C12N5/0682 , C07K16/00 , C07K2317/14 , C12N5/00 , C12N2500/60 , C12N2511/00 , C12P21/02
Abstract: An improved method for large scale production of proteins and/or polypeptides in cell culture is provided. In accordance with the present invention, the method provides for culturing cells that have metabolically shifted. The use of such a method or system allows high levels of protein or polypeptide production and reduces accumulation of unwanted metabolic waste such as lactate. Proteins and polypeptides expressed in accordance with the present invention may be advantageously used in the preparation of pharmaceutical, immunogenic, or other commercial biologic compositions, such as antibodies.
Abstract translation: 提供了用于在细胞培养物中大规模生产蛋白质和/或多肽的改进方法。 根据本发明,该方法提供培养具有代谢转移的细胞。 使用这种方法或系统允许高水平的蛋白质或多肽产生并减少不期望的代谢废物如乳酸盐的积累。 根据本发明表达的蛋白质和多肽可有利地用于制备药物,免疫原性或其他商业生物组合物,例如抗体。
-
-
-
-
-
-
-